ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Ponce Financial Group Inc
NASDAQ:PDLB
|
US |
Wall St Price Targets
ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ACAD is 32.8 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ACAD's stock price target?
Price Target
32.8
USD
According to Wall Street analysts, the average 1-year price target for ACAD is 32.8 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.
What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.
What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
27%
The compound annual growth rate for Operating Income over the next 8 years is 27%.
What is the Pre-Tax Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
34%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 34%.
What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Net Income over the next 8 years is 9%.
